The Gamma Knife Centre at QSRC is planning to undertake a number of important clinical trails on the clinical and cost effectiveness of Gamma Knife Radiosurgery.
An area of particular interest is cerebral metastases. Currently, the majority of patients with brain metastases are treated with whole brain radiation, and it has been the standard palliative procedure for the last 50 years. This method will give temporary relief to the patient; however the recipient may endure permanent brain damage leading to unacceptable consequences. In many countries the adoption of SRS in conjunction in many cases has proved to be the next logical and technology step.
Trials being planned will investigate the suitability for Gamma Knife Radiosurgery for patients with 4-10 brain metastases and novel MRI studies, working in partnership with the world-class imaging department at UCLH.
Fir further information about the plans for clinical trails please contact Pauline Richardson, Director of Operations email@example.com